Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML.

Clin Cancer Res. 1997 Mar;3(3):409-17.

2.

Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera.

Trehu EG, Mier JW, Dubois JS, Sorce D, Klempner MS, Epstein M, Dinarello CA, Shapiro L, Kappler K, Ronayne L, Atkins MB.

Clin Cancer Res. 1996 Aug;2(8):1341-51.

3.

Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.

Limentani SA, Pretell JO, Potter D, DuBois JS, Daoust PR, Spieler PS, Miller KB.

Am J Hematol. 1994 Sep;47(1):50-5.

PMID:
8042616
4.

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2.

Sparano JA, Brandt LJ, Dutcher JP, DuBois JS, Atkins MB.

Ann Intern Med. 1993 Apr 15;118(8):617-8. No abstract available.

PMID:
8452327
5.

Intramedullary fixation of fractures.

DuBOIS JS.

J Med Assoc State Ala. 1952 Jun;21(12):361-3. No abstract available.

PMID:
14938845
6.

Vaginal hysterectomy.

DUBOIS JS.

J Med Assoc State Ala. 1948 Aug;18(2):45-7. No abstract available.

PMID:
18875820

Supplemental Content

Loading ...
Support Center